•Outcomes from clinical trials and post-launch observational studies
•Payors/Regulators/HTAs 
•Healthcare professionals/Patient Advocacy Groups/Patients 
•Patient-level clinical research data with relevance to safety and effectiveness 
•Cost effectiveness analysis and pharmacoeconomic/health economic data